Poor-Prognosis Patients Affected by Glioblastoma: Retrospective Study of Hypofractionated Radiotherapy with Simultaneous Integrated Boost and Concurrent/Adjuvant Temozolomide

Poor-Prognosis Patients Affected by Glioblastoma: Retrospective Study of Hypofractionated Radiotherapy with Simultaneous Integrated Boost and Concurrent/Adjuvant Temozolomide

Background: Glioblastoma (GBM) is a very poor-prognosis brain tumor. To date, maximal excision followed by radiochemotherapy, in 30 fractions, is the standard approach. Limited data are present in the literature about hypofractionated radiotherapy (hypo-RT) in GBM poor prognosis patients. Thus, this...

Full description

Saved in:
Bibliographic Details
Main Authors: Fabiana Gregucci, Alessia Surgo, Ilaria Bonaparte, Letizia Laera, Maria Paola Ciliberti, Roberta Carbonara, Maria Annunziata Gentile, David Giraldi, Roberto Calbi, Morena Caliandro, Nicola Sasso, Salvatore D’Oria, Carlo Somma, Gaetano Martinelli, Giammarco Surico, Giuseppe Lombardi, Alba Fiorentino
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
glioblastoma
poor prognosis
radiotherapy
chemotherapy
Medicine
R
Online Access:https://doaj.org/article/af3579c3dc55499992afbba282d6db59
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/af3579c3dc55499992afbba282d6db59

Similar Items